Medical Information About Eczema News
Ask Questions, Save Lives; Risk Assessment Of Children's Respiratory Systems Identifies Potential Anesthetic ...
It is fairly easy to avoid surgical complications in children related to anesthesia administration by asking a few simple questions before arriving at the operating table. Britta S von Ungern-Sternberg from the Princess Margaret Hospital for Children, Subiaco, Australia, and international colleagues found that a risk evaluation questionnaire isolated and identified breathing side effects related ...
Read more...
Novartis Drug Tasigna® Approved In Switzerland After Fast-track Review For Treatment Of Patients With Newly Diagnosed ...
The Swiss health authority Swissmedic has granted approval for Tasigna® (nilotinib) 300 mg twice daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna is the first new therapeutic option for newly diagnosed patients since the introduction of Glivec® (imatinib), providing a major advance for ...
Read more...
KYTHERA And Bayer Dermatology Unit Intendis Enter Licensing And Development Agreement For Adipolytic Agent ATX-101
KYTHERA Biopharmaceuticals, Inc. ("KYTHERA") and Intendis, Bayer HealthCare's dermatology business, today announced that they have entered into a licensing agreement granting Intendis rights to KYTHERA's lead product candidate, ATX-101, outside of the US and Canada.
Read more...
Ask Dr. Gott: Are stress, baldness linked?
Dear Dr. Gott: My son has a bald spot on the back of his head. His doctor said it was stress-related alopecia. His hair grew back and his scalp was normal, but the bald spot reappeared, bigger, and is lasting much longer. So his doctor told him to buy Rogaine.
Read more...
Basilea announces distribution agreement with Actelion for Toctino(R) in Canada
BASEL, SWITZERLAND--(Marketwire - August 27, 2010) -
Read more...
|